Indications
Active immunisation of mink from 6 weeks of age to reduce infection and virus shedding following infection with SARS CoV2.
Composition
- Active substance
- recombinant SARS CoV2 spike protein
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Versiguard SARS CoV2
- Active substance
- recombinant SARS CoV2 spike protein
- ATC code
- QI20CX
- Group
- Veterinary medicines
- Marketing authorisation holder
- Zoetis Belgium
- Status
- Application withdrawn
- EMA product number
- EMEA/V/C/005988